Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Catalyst Pharmaceuticals Inc shares valued at $1,096,350 were sold by Miller Steve on Dec 10 ’24. At $21.93 per share, Miller Steve sold 50,000 shares. The insider’s holdings dropped to 686,996 shares worth approximately $15.84 million following the completion of this transaction.
Also, Miller Steve purchased 50,000 shares, netting a total of over 1,096,333 in proceeds.
Before that, INGENITO GARY had sold 12,000 shares from its account. In a trade valued at $272,654, the Chief Med. & Reg. Officer traded Catalyst Pharmaceuticals Inc shares for $22.72 each. Upon closing the transaction, the insider’s holdings decreased to 12,000 shares, worth approximately $1.19 million.
As published in their initiating research note from Robert W. Baird on February 04, 2025, Catalyst Pharmaceuticals Inc [CPRX] has been an Outperform and the price target has been revised to $28. Analysts at Stephens started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid November. As of March 14, 2024, Citigroup has initiated its “Buy” rating for CPRX. Earlier on March 07, 2024, BofA Securities initiated its rating. Their recommendation was “a Buy” for CPRX stock.
Analyzing CPRX Stock Performance
During the last five days, there has been a drop of approximately -0.56%. Over the course of the year, Catalyst Pharmaceuticals Inc shares have jumped approximately 10.49%. Shares of the company reached a 52-week high of $24.64 on 01/30/25 and a 52-week low of $19.15 on 01/08/25. A 50-day SMA is recorded $22.05, while a 200-day SMA reached $19.24. Nevertheless, trading volume fell to 1.24 million shares from 0.96 million shares the previous day.
Support And Resistance Levels for Catalyst Pharmaceuticals Inc (CPRX)
According to the 24-hour chart, there is a support level at 22.83, which, if violated, would cause prices to drop to 22.59. In the upper region, resistance lies at 23.47. The next price resistance is at 23.87. RSI (Relative Strength Index) is 54.61 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.25, which suggests the price will decrease in the coming days. Percent R is at 53.56%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
